Cargando…

A Functionally Superior Second-Generation Vector Expressing an Aurora Kinase-A-Specific T-Cell Receptor for Anti-Leukaemia Adoptive Immunotherapy

Aurora Kinase A is a cancer-associated protein normally involved in the regulation of mitosis. Being over-expressed in a range of cancers, it is a suitable target for cell-based immunotherapy. Gene transfer of T-cell receptor sequences cognisant of HLA-A*0201-restricted Aurora Kinase A antigen has p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casey, Nicholas Paul, Fujiwara, Hiroshi, Tanimoto, Kazushi, Okamoto, Sachiko, Mineno, Junichi, Kuzushima, Kiyotaka, Shiku, Hiroshi, Yasukawa, Masaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4896450/ https://www.ncbi.nlm.nih.gov/pubmed/27271876 http://dx.doi.org/10.1371/journal.pone.0156896

Ejemplares similares

A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression
por: Okamoto, Sachiko, et al.
Publicado: (2012)

Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injury
por: Asai, Hiroaki, et al.
Publicado: (2014)

Co-Introduced Functional CCR2 Potentiates In Vivo Anti-Lung Cancer Functionality Mediated by T Cells Double Gene-Modified to Express WT1-Specific T-Cell Receptor
por: Asai, Hiroaki, et al.
Publicado: (2013)

CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy
por: Wang, Yizheng, et al.
Publicado: (2023)

Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome
por: Wang, Linan, et al.
Publicado: (2016)

Genetic engineering of T cells with receptors from NY-ESO-1-specific tumor-recognizing CD4+ T cell as a novel approach for adoptive T cell therapy
por: Matsuzaki, Junko, et al.
Publicado: (2015)

A single-chain antibody generation system yielding CAR-T cells with superior antitumor function
por: Ochi, Toshiki, et al.
Publicado: (2021)

Tumor-specific donor lymphocyte infusion therapy with allogeneic T cells utilizing novel retrovirus vector silencing endogenous TCR expression
por: Ikeda, Hiroaki, et al.
Publicado: (2014)

Feasibility of gene-immunotherapy using WT1-specific T-cell receptor gene transfer for infant acute lymphoblastic leukemia with MLL gene rearrangement
por: Nagai, K, et al.
Publicado: (2011)

Application of Adoptive T-Cell Therapy Using Tumor Antigen-Specific T-Cell Receptor Gene Transfer for the Treatment of Human Leukemia
por: Ochi, Toshiki, et al.
Publicado: (2010)

Human herpesvirus 6 infection impairs Toll-like receptor signaling
por: Murakami, Yuichi, et al.
Publicado: (2010)

Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses
por: Matsuzaki, Junko, et al.
Publicado: (2015)

T cell receptor gene‐modified allogeneic T cells with siRNA for endogenous T cell receptor induce efficient tumor regression without graft‐versus‐host disease
por: Okada, Satomi, et al.
Publicado: (2023)

Direct comparison of target-reactivity and cross-reactivity induced by CAR- and BiTE-redirected T cells for the development of antibody-based T-cell therapy
por: Maruta, Masaki, et al.
Publicado: (2019)

In vivo persistence of adoptively transferred TCR gene-transduced lymphocytes with anti-tumor reactivity in patients with MAGE-A4 expressing esophageal cancer
por: Ikeda, Hiroaki, et al.
Publicado: (2013)

Systemic CD8(+) T Cell-Mediated Tumoricidal Effects by Intratumoral Treatment of Oncolytic Herpes Simplex Virus with the Agonistic Monoclonal Antibody for Murine Glucocorticoid-Induced Tumor Necrosis Factor Receptor
por: Ishihara, Mikiya, et al.
Publicado: (2014)

αβ-T cell receptor transduction gives superior mitochondrial function to γδ-T cells with promising persistence
por: Ishihara, Mikiya, et al.
Publicado: (2023)

Evolution of Resistance to Aurora Kinase B Inhibitors in Leukaemia Cells
por: Failes, Timothy W., et al.
Publicado: (2012)

Highly efficient genome editing for single-base substitutions using optimized ssODNs with Cas9-RNPs
por: Okamoto, Sachiko, et al.
Publicado: (2019)

P71. Adoptive transfer of TCR gene-transduced lymphocytes targeting MAGE-A4 for refractory esophageal cancer
por: Shiku, H, et al.
Publicado: (2014)

Exploring the Secrets of the Aurora: Second Edition
por: Akasofu, Syun-Ichi
Publicado: (2007)

Adoptive Immunotherapy for Hematological Malignancies Using T Cells Gene-Modified to Express Tumor Antigen-Specific Receptors
por: Fujiwara, Hiroshi
Publicado: (2014)

Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells
por: Sato, Osamu, et al.
Publicado: (2023)

Cancer immunotherapy; integration of T cell biology with nanogel- and vector-technology in translational research
por: Shiku, Hiroshi
Publicado: (2012)

Targeting aurora kinases as a potential prognostic and therapeutical biomarkers in pediatric acute lymphoblastic leukaemia
por: Moreira-Nunes, Caroline Aquino, et al.
Publicado: (2020)

Immunotherapy in leukaemia: Immunotherapy in leukaemia
por: Mu, Xingmei, et al.
Publicado: (2023)

Active immunotherapy in acute myelogenous leukaemia and the induction of second and subsequent remissions.
por: Harris, R., et al.
Publicado: (1978)

Aurora-C Interactions with Survivin and INCENP Reveal Shared and Distinct Features Compared with Aurora-B Chromosome Passenger Protein Complex
por: Sasai, Kaori, et al.
Publicado: (2016)

Role of latent membrane protein 1 in chronic active Epstein–Barr virus infection-derived T/NK-cell proliferation
por: Ito, Takuto, et al.
Publicado: (2014)

Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy
por: Sandri, Sara, et al.
Publicado: (2017)

Optical Flow-Based Analysis of the Relationships between Leaf Wilting and Stem Diameter Variations in Tomato Plants
por: Wakamori, Kazumasa, et al.
Publicado: (2019)

Engineered T Cells for the Adoptive Therapy of B-Cell Chronic Lymphocytic Leukaemia
por: Koehler, Philipp, et al.
Publicado: (2012)

Aurora /
por: López Colomé, Pura, 1952-
Publicado: (1994)

Aurora
por: Böhme, Jacob
Publicado: (1979)

Aurora /
por: Leiris, Michel, 1901-
Publicado: (1977)

Aurora
por: Nietzsche, Friedrich Wilhelm, 1844-1900
Publicado: (1996)

Aurora
por: Jones, Alister Vallance
Publicado: (1974)

Auroras : poesías
por: Morandeyra, Mary
Publicado: (1929)

The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib
por: Kelly, Kevin R, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3dt6fbml7tg6damq94mvilq93i